Reference
- VANDER JAGT DL et al.: Substrate specificity of human aldose reductase identification of 4-hydroxynonenal as an endogenous substrate. Biochim. Biophys. Acta (1995) 1249: 117–126.
- PENNING TM et al.: Mammalian 3 alpha-hydroxysteroid dehydrogenases. Steroids (1997) 62:455–456.
- TAKAHASHI M et al.: Induction of aldose reductase gene expression in LEG rats during the development of the hereditary hepatitis and hepatoma. Jpn. J. Cancer Res. (1996) 87:337–341.
- GAO DL et al.: Induction and cellular location of aldose reductase and an aldose reductase-like gene in human primary liver cancers (Meeting abstract). Proceedings of the Annual Meeting of the American Association of Cancer Research (1996).
- ZEINDL-EBERHART E et al.: Identification of tumor-associated protein variants during rat hepatocarcinogenesis. Aldose reductase. J. Biol. Chem. (1994) 269:14589–14594.
- FELSTED RL et al.: Rat liver daunorubicin reductase. An aldo-keto reductase. I. Biol. Chem. (1974) 249:3672–3679.
- PAREKH HK et al.: NADPH-dependent enzyme-catalyzed reduction of aldophosphamide, the pivotal metabolite of cyclophosphamide. Biochem. Pharmacol. (1993) 46:1043–1052.
- WILSON DK et al.: Refined 1.8 A structure of human aldose reductase complexed with the potent inhibitor zopolrestat. Proc. Natl. Acad. Sci. USA (1993) 90:9847–9851.
- WILSON DK et al.: 1.7 A structure of FR-1, a fibroblast growth factor-induced member of the aldo-keto reductase family, complexed with coenzyme and inhibitor. Biochemistry (1995) 34:14323–14330.